ACN Form 4: Chair/CEO Buys 152 Shares at $254.42

Q: What did Julie Spellman Sweet report on Form 4 for ACN?

She reported purchasing 152 Class A ordinary shares on 09/05/2025 at $254.42 per share, bringing her direct beneficial ownership to 8,440 shares.

Q: When was the insider purchase executed and when was the Form 4 signed?

Transaction date: 09/05/2025. Form signed: 09/08/2025 by an attorney-in-fact for the reporting person.

Q: Does the Form 4 show any derivative transactions or dispositions?

No. The filing lists only a non-derivative acquisition of Class A ordinary shares and reports no dispositions or derivative instruments.

Q: What is the price per share reported for the transaction?

$254.42 per share as disclosed in the Form 4 for the 09/05/2025 acquisition.

[Form 4] Accenture PLC Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Julie Spellman Sweet, Chair and CEO of Accenture plc (ACN), purchased 152 Class A ordinary shares on 09/05/2025 at a price of $254.42 per share under Accenture's Voluntary Equity Investment Program. After the transaction she beneficially owns 8,440 shares, held directly. The Form 4 was signed on 09/08/2025 by an attorney-in-fact. The filing records the acquisition as a routine employee/insider purchase from the company program and discloses no derivatives, dispositions, or additional material terms.

Positive

Insider acquisition disclosed: Chair and CEO purchased 152 shares, increasing direct ownership to 8,440 shares.
Transaction executed under an established program: Purchase was made via Accenture's Voluntary Equity Investment Program, a routine company mechanism.

Negative

None.

Insights

TL;DR: A small, routine insider purchase of 152 shares by Accenture's Chair and CEO under the company equity program; ownership now 8,440 shares.

This Form 4 documents a straightforward acquisition under the company's Voluntary Equity Investment Program. The transaction was executed on 09/05/2025 at $254.42 per share and increases the reporting person's direct holdings to 8,440 Class A ordinary shares. The position size and purchase amount are modest relative to a large-cap issuer and do not, by themselves, indicate a material change in insider exposure or company capitalization. No options, dispositions, or complex terms were reported.

TL;DR: Filing shows compliance with Section 16 reporting for a routine equity program purchase by a named executive officer and director.

The Form 4 properly discloses the transaction date, price, class of shares, and resulting beneficial ownership. It also identifies the acquisition as occurring under Accenture's Voluntary Equity Investment Program and is signed by an attorney-in-fact, indicating procedural adherence. There are no disclosure gaps in the form text provided; no related-party transfers, derivatives, or unusual timing are evident from the filing.

09/08/2025 - 04:27 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sweet Julie Spellman

(Last)

(First)

(Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO

60661

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A ordinary shares	09/05/2025		A		152⁽¹⁾	A	$254.42	8,440	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program.

Remarks:

	/s/ Danika Haueisen, Attorney-In-Fact for Julie Spellman Sweet	09/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did Julie Spellman Sweet report on Form 4 for ACN?

She reported purchasing 152 Class A ordinary shares on 09/05/2025 at $254.42 per share, bringing her direct beneficial ownership to 8,440 shares.

When was the insider purchase executed and when was the Form 4 signed?

Transaction date: 09/05/2025. Form signed: 09/08/2025 by an attorney-in-fact for the reporting person.

Under what plan were the Accenture shares acquired?

The shares were purchased under Accenture's Voluntary Equity Investment Program, as stated in the Form 4 explanation.

Does the Form 4 show any derivative transactions or dispositions?

No. The filing lists only a non-derivative acquisition of Class A ordinary shares and reports no dispositions or derivative instruments.

What is the price per share reported for the transaction?

$254.42 per share as disclosed in the Form 4 for the 09/05/2025 acquisition.

AG真人官方

[Form 4] Accenture PLC Insider Trading Activity

Insights

FAQ

What did Julie Spellman Sweet report on Form 4 for ACN?

When was the insider purchase executed and when was the Form 4 signed?

Under what plan were the Accenture shares acquired?

Does the Form 4 show any derivative transactions or dispositions?

What is the price per share reported for the transaction?

NYSE:ACN

ACN Rankings

ACN Latest News

ACN Latest SEC Filings

ACN Stock Data

AG真人官方

Trending News

[Form 4] Accenture PLC Insider Trading Activity

Insights

Securities Analyst neutral

Corporate Governance Expert neutral

FAQ

What did Julie Spellman Sweet report on Form 4 for ACN?

When was the insider purchase executed and when was the Form 4 signed?

Under what plan were the Accenture shares acquired?

Does the Form 4 show any derivative transactions or dispositions?

What is the price per share reported for the transaction?

NYSE:ACN

ACN Rankings

ACN Latest News

ACN Latest SEC Filings

ACN Stock Data